Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Merck, known as MSD outside the United States and Canada, announced today that the pivotal Phase 3 KEYNOTE-048 trial investigating KEYTRUDA, Merck's anti-PD-1 therapy, for first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma, met a primary endpoint of overall survival as monotherapy in patients whose tumors expressed PD-L1.

25 Jul 2018

Patients with colon cancers on the right side have worse survival rates than those with left-sided tumors

Patients with colorectal cancer tumors on the right side may have poorer five-year survival rates than those whose tumors are located on the left side.

24 Jul 2018

Replacing conventional cancer treatment with complementary therapy linked to increased risk of death

People who received complementary therapy for curable cancers were more likely to refuse at least one component of their conventional cancer treatment, and were more likely to die as a result, according to researchers from Yale Cancer Center and the Cancer Outcomes, Public Policy and Effectiveness Research Center at Yale School of Medicine.

20 Jul 2018

New proteomics studies help gain more insights into Alzheimer's, cancer and listeriosis

The brains of people with Alzheimer's disease contain many protein aggregates outside of cells, known as plaques. These are mainly made of the peptide amyloid-beta, which is released from the plasma membrane when the protease BACE1 cleaves its membrane-anchored precursor protein.

19 Jul 2018

Weight loss surgery may impact individual's risk of developing cancer, shows study

A new analysis published in the BJS indicates that weight loss surgery may affect an individual's risk of developing cancer.

16 Jul 2018

Mailing colorectal cancer tests to patients increases screening rates, report researchers

Mailing colorectal cancer screening tests to patients insured by Medicaid increased screening rates for this population, report researchers at the University of North Carolina Comprehensive Cancer Center.

16 Jul 2018

Researchers uncover evolutionary history of IBD-associated bowel cancer

A team of researchers from Queen Mary University of London have reported the genetic events involved in the early development of bowel cancer in patients with inflammatory bowel disease.

11 Jul 2018

American Cancer Society outlines vision for cancer control in the decades ahead

The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that begins publishing today.

11 Jul 2018

Younger rectal cancer patients do not experience survival benefit from currently recommended therapies

A new study reveals that individuals younger than 50 years of age who are diagnosed with rectal cancer do not experience an overall survival benefit from currently recommended treatments.

9 Jul 2018

Study shows precision medicine improves outcomes in pancreatic cancer patients

A study published today by the Pancreatic Cancer Action Network, Perthera, Inc., and colleagues in the AACR journal Clinical Cancer Research found for the first time that precision medicine can improve outcomes and provide clinically meaningful information to pancreatic cancer patients.

28 Jun 2018

A small molecule can inhibit chemotherapy resistance of certain tumors

A team of researchers from the CNRS and Université Nice Sophia Antipolis has just shown that a small molecule called methiothepin can inhibit the chemotherapy resistance of certain tumors.

28 Jun 2018

New nuclear medicine approach shows potential for precision treatment of solid tumors

A novel nuclear medicine approach is showing great promise for precision treatment of solid tumors in many types of cancer--including lung, breast, pancreas and ovarian in adults and glioma, neuroblastoma and sarcoma in children.

26 Jun 2018

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for standard review a new supplemental Biologics License Application for KEYTRUDA, Merck's anti-PD-1 therapy, as adjuvant therapy in the treatment of patients with resected, high-risk stage III melanoma and granted a Prescription Drug User Fee Act, or target action, date of February 16, 2019.

25 Jun 2018

WVU researchers increase colorectal cancer screening rates in West Virginia

In West Virginia, where colorectal cancer is the second-deadliest type of cancer, half of all colorectal cancers elude diagnosis until they have already grown beyond the colon. With Medicaid expansion, more West Virginians now have health insurance for cancer screening, yet many barriers to screening persist.

21 Jun 2018

Study: Oxidative stress can be used against tumors to treat cancer

Oxidative stress can help tumors thrive, but one way novel cancer treatments work is by pushing levels to the point where it instead helps them die, scientists report.

21 Jun 2018

Clinical trial targets metastatic colorectal cancer with new combination therapy

Rutgers Cancer Institute of New Jersey is offering a clinical trial targeting an advanced form of colorectal cancer with a combination vaccine/immunotherapy drug treatment.

19 Jun 2018

Diabetes diagnosis may come with increased risk of pancreatic cancer for African-Americans, Latinos

Each year, more than one million Americans are diagnosed with adult-onset diabetes mellitus, also known as type 2 diabetes. The new diagnosis comes with a long list of potential complications: high blood pressure, nerve damage, kidney disease, stroke, glaucoma and more.

18 Jun 2018

Recent-onset type 2 diabetes may be early expression of pancreatic cancer

A new study in the Journal of the National Cancer Institute, published by Oxford University Press, indicates that recent-onset type 2 diabetes may be early expression of pancreatic cancer.

18 Jun 2018

Higher circulating vitamin D levels linked with lower colorectal cancer risk

A new study authored by scientists from the American Cancer Society, the Harvard T.H. Chan School of Public Health, the U.S. National Cancer Institute, and more than 20 other medical centers and organizations finds that higher circulating vitamin D concentrations are significantly associated with lower colorectal cancer risk.

14 Jun 2018

Innovative concept for implementing WHO resolution to safeguard quality of cancer treatment

Cancer is a burden to those affected by it and a growing challenge to the political sector. In 2017, WHO therefore issued an international resolution to safeguard the quality of cancer treatment, and access to it, in every country in the world.

14 Jun 2018

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Patients with colon cancers on the right side have worse survival rates than those with left-sided tumors

Replacing conventional cancer treatment with complementary therapy linked to increased risk of death

New proteomics studies help gain more insights into Alzheimer's, cancer and listeriosis

Weight loss surgery may impact individual's risk of developing cancer, shows study

Mailing colorectal cancer tests to patients increases screening rates, report researchers

Researchers uncover evolutionary history of IBD-associated bowel cancer

American Cancer Society outlines vision for cancer control in the decades ahead

Younger rectal cancer patients do not experience survival benefit from currently recommended therapies

Study shows precision medicine improves outcomes in pancreatic cancer patients

A small molecule can inhibit chemotherapy resistance of certain tumors

New nuclear medicine approach shows potential for precision treatment of solid tumors

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

WVU researchers increase colorectal cancer screening rates in West Virginia

Study: Oxidative stress can be used against tumors to treat cancer

Clinical trial targets metastatic colorectal cancer with new combination therapy

Diabetes diagnosis may come with increased risk of pancreatic cancer for African-Americans, Latinos

Recent-onset type 2 diabetes may be early expression of pancreatic cancer

Higher circulating vitamin D levels linked with lower colorectal cancer risk

Innovative concept for implementing WHO resolution to safeguard quality of cancer treatment

Innovation in neuroscience drug discovery - eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Innovation in neuroscience drug discovery - eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in